SARS-CoV-2 wildlife surveillance in Ontario and Québec.
Ontario
Québec
SARS-CoV-2
surveillance
wildlife
Journal
Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729
Informations de publication
Date de publication:
09 Jun 2022
09 Jun 2022
Historique:
medline:
19
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 pandemic, is capable of infecting a variety of wildlife species. Wildlife living in close contact with humans are at an increased risk of SARS-CoV-2 exposure and, if infected, have the potential to become a reservoir for the pathogen, making control and management more difficult. The objective of this study is to conduct SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec, increasing our knowledge of the epidemiology of the virus and our chances of detecting spillover from humans into wildlife. Using a One Health approach, we leveraged activities of existing research, surveillance and rehabilitation programs among multiple agencies to collect samples from 776 animals from 17 different wildlife species between June 2020 and May 2021. Samples from all animals were tested for the presence of SARS-CoV-2 viral ribonucleic acid, and a subset of samples from 219 animals across three species (raccoons, No evidence of SARS-CoV-2 viral ribonucleic acid or neutralizing antibodies was detected in any of the tested samples. Although we were unable to identify positive SARS-CoV-2 cases in wildlife, continued research and surveillance activities are critical to better understand the rapidly changing landscape of susceptible animal species. Collaboration between academic, public and animal health sectors should include experts from relevant fields to build coordinated surveillance and response capacity.
Sections du résumé
Background
UNASSIGNED
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 pandemic, is capable of infecting a variety of wildlife species. Wildlife living in close contact with humans are at an increased risk of SARS-CoV-2 exposure and, if infected, have the potential to become a reservoir for the pathogen, making control and management more difficult. The objective of this study is to conduct SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec, increasing our knowledge of the epidemiology of the virus and our chances of detecting spillover from humans into wildlife.
Methods
UNASSIGNED
Using a One Health approach, we leveraged activities of existing research, surveillance and rehabilitation programs among multiple agencies to collect samples from 776 animals from 17 different wildlife species between June 2020 and May 2021. Samples from all animals were tested for the presence of SARS-CoV-2 viral ribonucleic acid, and a subset of samples from 219 animals across three species (raccoons,
Results
UNASSIGNED
No evidence of SARS-CoV-2 viral ribonucleic acid or neutralizing antibodies was detected in any of the tested samples.
Conclusion
UNASSIGNED
Although we were unable to identify positive SARS-CoV-2 cases in wildlife, continued research and surveillance activities are critical to better understand the rapidly changing landscape of susceptible animal species. Collaboration between academic, public and animal health sectors should include experts from relevant fields to build coordinated surveillance and response capacity.
Identifiants
pubmed: 37333575
doi: 10.14745/ccdr.v48i06a02
pii: 480602
pmc: PMC10273785
doi:
Types de publication
Journal Article
Langues
eng
Pagination
243-251Informations de copyright
Public Health Agency of Canada, 2022.
Déclaration de conflit d'intérêts
Competing interests: None.
Références
Emerg Infect Dis. 2007 Sep;13(9):1295-300
pubmed: 18252098
J Gen Virol. 2009 Aug;90(Pt 8):2015-2022
pubmed: 19357225
Vet Pathol. 2020 Sep;57(5):653-657
pubmed: 32663073
PLoS One. 2011;6(7):e21693
pubmed: 21789177
Nat Commun. 2021 Jun 14;12(1):3612
pubmed: 34127676
Proc Natl Acad Sci U S A. 2021 Nov 2;118(44):
pubmed: 34716263
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
Emerg Infect Dis. 2021 Feb;27(2):547-551
pubmed: 33207152
Viruses. 2021 Sep 25;13(10):
pubmed: 34696363
Emerg Infect Dis. 2022 Feb;28(2):467-470
pubmed: 35076003
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Emerg Infect Dis. 2021 Aug;27(8):2073-2080
pubmed: 34286685
Sci Total Environ. 2020 Sep 1;733:139358
pubmed: 32416535
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):
pubmed: 34732584
Vet Q. 2021 Dec;41(1):250-267
pubmed: 34406913
FASEB J. 2020 Dec;34(12):15946-15960
pubmed: 33015868
Nature. 2022 Feb;602(7897):481-486
pubmed: 34942632
J Virol. 2021 Mar 10;95(11):
pubmed: 33692203
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
One Health Outlook. 2021 Apr 7;3:7
pubmed: 33834160
EMBO Mol Med. 2022 Mar 7;14(3):e15558
pubmed: 35083854
PLoS Pathog. 2020 Sep 3;16(9):e1008758
pubmed: 32881980
Euro Surveill. 2021 Feb;26(5):
pubmed: 33541485
Front Vet Sci. 2022 Jan 12;8:715307
pubmed: 35097038
Transbound Emerg Dis. 2022 Sep;69(5):3001-3007
pubmed: 34080762
Animals (Basel). 2021 May 16;11(5):
pubmed: 34065657
Transbound Emerg Dis. 2021 Jul;68(4):1850-1867
pubmed: 33091230
Transbound Emerg Dis. 2022 Sep;69(5):3016-3021
pubmed: 34224205
Viruses. 2021 Oct 04;13(10):
pubmed: 34696423
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35078920
Transbound Emerg Dis. 2021 Nov;68(6):3443-3452
pubmed: 33295095
J Clin Virol. 2020 Jul;128:104433
pubmed: 32405254